Skip to main content

Table 2 Univariate and multivariate analysis of overall survival

From: Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study

Variables

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Age (≥ 70 vs <  70)

2.023 (0.955–4.287)

0.066

  

Sex (female vs male)

1.195 (0.544–2.624)

0.658

  

BMI (<  25 vs ≥ 25)

1.977 (0.754–5.183)

0.166

  

Comorbidities

 Myocardial infarction

3.510 (1.057–11.655)

0.040

1.825 (0.520–6.413)

0.348

 Congestive heart failure

2.848 (0.990–8.194)

0.052

  

 Cerebrovascular accident

1.330 (0.316–5.603)

0.697

  

 COPD

1.393 (0.331–5.858)

0.651

  

 Liver disease

4.267 (1.291–14.108)

0.017

3.514 (0.868–14.235)

0.078

 Chronic kidney disease

6.615 (0.863–50.679)

0.069

  

 Diabetes mellitus

1.460 (0.647–3.297)

0.363

  

Stage

 (II vs I)

2.766 (1.003–7.629)

0.049

1.211 (0.314–4.671)

0.781

 (III vs I)

8.214 (3.437–19.631)

< 0.001

3.042 (0.784–11.812)

0.108

Tumor size (≥ 50 vs < 50)

3.210 (1.543–6.678)

0.002

1.080 (0.441–2.648)

0.866

Lymphatic vessel infiltration

5.739 (2.335–14.104)

< 0.001

3.054 (0.879–10.612)

0.079

Histologic type (Intestinal vs Diffuse)

1.089 (0.52–2.280)

0.821

  

Lymph node dissection

 (D1+ vs D1)

3.760 (0.854–16.550)

0.080

  

 (D2 vs D1)

3.262 (0.736–14.459)

0.120

  

Complication (CD ≥ 3)

1.659 (0.394–6.982)

0.490

  

Complication (infection)

2.343 (0.815–6.739)

0.114

  

CEA (≥ 5.5 vs < 5.5)

2.306 (0.939–5.665)

0.068

  

CA19–9 (37 vs < 37)

2.825 (1.150–6.938)

0.024

1.340 (0.453–3.961)

0.597

mGPS (0 vs 1,2)

2.519 (0.343–18.517)

0.364

  

NLR (≥ 2.5 vs < 2.5)

1.182 (0.55–2.542)

0.669

  

PNI (<  45 vs ≥ 45)

4.261 (1.734–10.47)

0.002

2.889 (1.104–7.563)

0.031

  1. HR hazard ratio, CI confidential index. Variables in bold are statistically significant (P < 0.05)
  2. BMI body mass index, COPD chronic obstructive pulmonary disease, CD Clavien-Dindo Classification, CEA carcinoembryonic antigen, CA19–9 carbohydrate antigen 19–9, mGPS modified Glasgow Prognostic Score, NLR neutrophil-to-lymphocyte ratio, PNI prognostic nutritional index